glp-1 and oral contraceptives How GLP-1s Impact Birth Control GLP-1s (Weight loss injections) AND

Editor information Editors and Affiliations Rights and permissions Copyright information 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG About this chapter Cite this chapter Namin, A., Brown, R.F

However, some people may experience mild soreness at the injection site or redness

Subsequently, other drugs such as Novos Victoza (liraglutide, approved in 2010), AstraZenecas Bydureon (exenatide, 2012), GSKs Tanzeum (albiglutide, 2014), Lillys Trulicity (dulaglutide, 2014) and Novos Ozempic (semaglutide, 2017) and Rybelsus (oral semaglutide, 2019) were approved

Blood samples were assessed 24 hours after doses were administered

doi: 10.1186/s12876-016-0446-z 28 GargariG.TavernitiV.GardanaC.CremonC.CanducciF.PaganoI.et al

(d) Saxagliptin, PDB ID 3bjm (Metzler et al., 2008)